Jana Portnow

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Christine E. Brown, Darya Alizadeh, Renate Starr et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

Cell Therapy, Immunology, Immune Regulation +17

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

Christine E. Brown, Behnam Badie, Michael E. Barish et al. · Clinical Cancer Research · 2015 · 733 citations · Full text

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia et al. · Journal of the National Comprehensive Cancer Network · 2020 · 538 citations · Full text

Surgical Oncology, Cancer Management, High-grade Gliomas +19

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 528 citations · Full text